5 Cardiovascular SaMD Cleared in 2023 | By Randy Horton, Chief Solutions Officer, Orthogonal

Mr. Horton advises this article takes a quick look at five interesting SaMD from the Cardiovascular panel that were cleared by the FDA in 2023. The common thread among these recently cleared SaMD is a focus on remotely monitoring patients and alerting them or their clinicians when irregular heart rhythms or dangerous heart events occur.